Related Experiment Video
Updated: Jun 24, 2026

07:44
Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay
Published on: March 12, 2018
10.0K
PET image nonuniformity texture features for metastasis risk prediction in osteosarcoma
Muath Almaslamani1,2, Byung-Hyun Byun3, Kanghyon Song3
1Radiological and Medico-Oncological Sciences, University of Science and Technology, Daejeon, Republic of Korea.
Nuclear Medicine Communications
|May 6, 2025
Summary
Combining PET image texture and Ki-67 expression improves metastasis prediction in osteosarcoma. This multimodal approach aids personalized treatment planning for patients with osteosarcoma.
Area of Science:
- Oncology
- Radiology
- Medical Imaging
Background:
- Osteosarcoma metastasis risk and chemotherapy response are linked to tumor heterogeneity.
- Ki-67 expression is a known predictor of metastasis in osteosarcoma.
- Integrating imaging and molecular data can enhance predictive model accuracy.
Purpose of the Study:
- To evaluate the accuracy of combining 18F-fluorodeoxyglucose PET image texture features and Ki-67 expression for predicting metastasis in osteosarcoma.
- To assess the predictive value of gray-level run length matrix (GLRLM) run length nonuniformity (RLNU) for neoadjuvant chemotherapy response (NACR) and metastatic events.
Main Methods:
- Collected PET images and clinical data from 82 osteosarcoma patients.
- Extracted quantitative texture features from pre-treatment PET images.
- Utilized machine learning (random forest) with GLRLM RLNU, Ki-67, and NACR for metastasis prediction.
Main Results:
- GLRLM RLNU was significantly associated with NACR and metastatic risk (P < 0.05).
- A random forest model incorporating GLRLM RLNU, Ki-67, and NACR achieved 0.91 accuracy in predicting metastatic risk.
- PET image texture nonuniformity demonstrated high accuracy in predicting NACR and metastatic risk.
Conclusions:
- Combining PET image texture nonuniformity with Ki-67 expression and clinical data improves metastasis prediction accuracy in osteosarcoma.
- This multimodal approach offers a promising tool for metastasis risk stratification.
- Personalized treatment strategies for osteosarcoma can be supported by this enhanced predictive model.

